Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII).

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Thrombosis and Haemostasis

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1538-7836.2007.02819.XPMID 17973650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Minnesota Code Manual of Electrocardiographic Findings

  2009cited by this paper
• Tissue Factor in Cardiovascular Diseases: Molecular Mechanisms and Clinical Implications

  2006cited by this paper
• Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.

  2006cited by this paper
• Does Inflammatory Proteolytic Activity Contribute to the Increased Factor IX Activation Peptide in Men at High Risk of Coronary Heart Disease? A Preliminary Study

  2002cited by this paper
• Fibrin D-Dimer and Coronary Heart Disease: Prospective Study and Meta-Analysis

  2001cited by this paper
• Comparison of Novel Hemostatic Factors and Conventional Risk Factors for Prediction of Coronary Heart Disease

  2000cited by this paper
• Neutrophil elastase cleavage of human factor IX generates an activated factor IX-like product devoid of coagulant function.

  1998cited by this paper
• Atherosclerosis is an Inflammatory Disease

  1998cited by this paper
• Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.

  1998cited by this paper
• Macrophages and atherosclerotic plaque stability

  1996cited by this paper
• Increased Activation of the Haemostatic System in Men at High Risk of Fatal Coronary Heart Disease

  1996cited by this paper
• An enzyme-linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman factor) in human plasma.

  1996cited by this paper
• The Effects of Quality and Timing of Venepuncture on Markers of Blood Coagulation in Healthy Middle-aged Men

  1995cited by this paper
• Factor VII-Deficient Substrate Plasmas Depleted of Protein C Raise the Sensitivity of the Factor VII Bio-Assay to Activated Factor VII: an International Study

  1994cited by this paper
• Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation

  1993cited by this paper
• Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.

  1993cited by this paper
• Plasma levels of elastase-specific fibrinopeptides correlate with proteinase inhibitor phenotype. Evidence for increased elastase activity in subjects with homozygous and heterozygous deficiency of alpha 1-proteinase inhibitor.

  1992cited by this paper
• Factor IX is activated in vivo by the tissue factor mechanism.

  1990cited by this paper
• DETECTION OF FACTOR X ACTIVATION IN HUMANS

  1989cited by this paper
• Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death.

  1984cited by this paper
• Human plasma kallikrein releases neutrophil elastase during blood coagulation.

  1983cited by this paper
• Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex.

  1982cited by this paper
• Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction.

  1980cited by this paper
• SKIN DISEASE AND THE BOWEL.

  1965cited by this paper
• [Rapid physiological coagulation method in determination of fibrinogen].

  1957cited by this paper
• Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens

  1957cited by this paper
• Recent history of coronary disease.

  1951cited by this paper
• Thrombosis as a factor in the pathogenesis of coronary atherosclerosis.

  1946cited by this paper

• Thomas Wilson Meade. 21 January 1936 — 24 October 2022

  2024cites this paper
• A novel factor IXa–specific enzyme-linked immunosorbent assay detects factor IXa in human plasma

  2024cites this paper
• Association of micronutrients and haemopoietic parameters with glucose in diabetics in a rural area of the Limpopo Province, South Africa

  2022cites this paper
• ASSOCIATION OF COAGULATION FACTORS WITH THE PRESENCE OF UNSTABLE ATHEROSCLEROTIC PLAQUES IN THE CORONARY ARTERIES

  2018cites this paper
• Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study

  2017cites this paper
• Alterations in D-Dimer, Prothrombin Time and Activated Partial Thromboplastin Time as Thrombogenesis Activity Markers in Patients with Acute Myocardial Infarction

  2016cites this paper
• Activated factor VII–antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study

  2016cites this paper
• The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us?

  2014cites this paper
• Haemostatic factors, lipoproteins and long-term mortality in a multi-ethnic population of Gujarati, African-Caribbean and European origin.

  2014cites this paper
• A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial.

  2013cites this paper
• Changes in haemostatic and platelet activation markers in non-dipper hypertensive patients

  2012cites this paper
• Factor IXa as a target for pharmacologic inhibition in acute coronary syndrome.

  2011cites this paper
• Mice Exposed to Chronic Intermittent Hypoxia Simulate Clinical Features of Deficiency of both Qi and Yin Syndrome in Traditional Chinese Medicine

  2011cites this paper
• Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy.

  2011cites this paper
• Thrombin generation in patients with a first acute myocardial infarction

  2011cites this paper
• Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men

  2010cites this paper
• Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis

  2010cites this paper
• Antithrombotic Therapy in Acute Coronary Syndrome: How Far Up the Coagulation Cascade Will We Go?

  2010cites this paper
• Coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease.

  2010cites this paper
• Aterosclerosis: biomarcadores plasmáticos emergentes

  2010cites this paper
• Associations of Thrombotic-Hemostatic Factors with Cardiovascular Disease~!2009-10-29~!2009-12-22~!2010-04-08~!

  2010cites this paper
• Increased phosphatidylserine exposure on platelets from hospitalized patients with acute medical illnesses.

  2009cites this paper
• FVII, FVIIa, and Downstream Markers of Extrinsic Pathway Activation Differ by EPCR Ser219Gly Variant in Healthy Men

  2009cites this paper
• C-reactive protein and coronary heart disease: predictive test or therapeutic target?

  2009cites this paper
• Factor IX and deep vein thrombosis

  2009cites this paper
• Disturbances of coagulation in neonates with functionally univentricular physiology prior to the first stage of surgical reconstruction

  2008cites this paper
• Coagulation factors, activation markers and risk of coronary heart disease: the Northwick Park Heart Studies

  2008cites this paper
• American Journal of Epidemiology Original Contribution Free Protein S Level as a Risk Factor for Coronary Heart Disease and Stroke in a Prospective Cohort Study of Healthy United Kingdom Men

  year unknowncites this paper
• O R I G I N a L C L I N I C a L I N V E S T I G a T I O N Open Access

  year unknowncites this paper